


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:51:22Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406297" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406297</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="case-report" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Case Rep</journal-id><journal-id journal-id-type="pmc-domain-id">694</journal-id><journal-id journal-id-type="pmc-domain">bmjgroup</journal-id><journal-id journal-id-type="publisher-id">bcr</journal-id><journal-title-group><journal-title>BMJ Case Reports</journal-title></journal-title-group><issn pub-type="epub">1757-790X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>BMJ Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406297</article-id><article-id pub-id-type="pmcid-ver">PMC12406297.1</article-id><article-id pub-id-type="pmcaid">12406297</article-id><article-id pub-id-type="pmcaiid">12406297</article-id><article-id pub-id-type="pmid">40858342</article-id><article-id pub-id-type="doi">10.1136/bcr-2025-266121</article-id><article-id pub-id-type="publisher-id">bcr-2025-266121</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Surgery</subject></subj-group></article-categories><title-group><article-title>Surgical resection of abdominal and cardiac metastasis of thigh myxoid liposarcoma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Powell</surname><given-names initials="E">Emma</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Coveney</surname><given-names initials="A">Andrew</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hodder</surname><given-names initials="R">Rupert</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><aff id="aff1"><label>1</label><institution content-type="department">Urology</institution>, <institution specific-use="Ringgold_5728">Sir Charles Gairdner Hospital</institution>, <city>Nedlands</city>, <state>Western Australia</state>, <country>Australia</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Colorectal Surgery</institution>, <institution specific-use="Ringgold_5728">Sir Charles Gairdner Hospital</institution>, <city>Nedlands</city>, <state>Western Australia</state>, <country>Australia</country></aff><aff id="aff3"><label>3</label><institution content-type="department">Department of Surgery</institution>, <institution specific-use="Ringgold_5728">Sir Charles Gairdner Hospital</institution>, <city>Nedlands</city>, <state>Western Australia</state>, <country>Australia</country></aff></contrib-group><author-notes><fn fn-type="COI-statement" id="fn3"><p>None declared.</p></fn><corresp id="cor1">Dr Emma Powell; <email xlink:href="emmapowell43@gmail.com">emmapowell43@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>26</day><month>8</month><year>2025</year></pub-date><volume>18</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">496139</issue-id><elocation-id>e266121</elocation-id><history><date date-type="received"><day>24</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>30</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; BMJ Publishing Group Limited 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:&#160;<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="bcr-18-8.pdf"/><self-uri xlink:title="pdf" xlink:href="bcr-18-8.pdf"/><abstract><title>Summary</title><p>We present a case of successful resection of a fourth recurrence of oligometastatic myxoid liposarcoma to the retroperitoneum. This case highlights the importance of centralised sarcoma centres with high surgical and patient volume, extensive perioperative work-up and the multidisciplinary management of patients with sarcoma. Perioperative work-up included a CT coronary angiogram, which identified intraventricular cardiac metastasis. The patient underwent a successful resection of the cardiac lesion prior to laparotomy, excision of right iliac fossa mass with en bloc ileocolic resection, excision of right adrenal metastasis and insertion of right JJ stent.</p></abstract><kwd-group><kwd>General surgery</kwd><kwd>Surgical oncology</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="background" id="s1"><title>Background</title><p> Sarcomas are a rare and diverse group of malignant tumours arising from mesenchymal tissue.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> They account for less than 1% of all adult cancers and about 10% of paediatric cancers. Around 80% of newly diagnosed sarcomas develop in soft tissues, while the remaining cases originate in the bone.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Liposarcomas are one of the most common histological subtypes in adults and can be further sub-categorised into typical lipomatous tumour/well-differentiated, dedifferentiated liposarcoma and myxoid liposarcoma (MLPS). MLPS accounts for 15&#8211;20% of liposarcomas.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref></p><p>In contrast to other sarcomas that most commonly metastasise to the lung, MLPS more commonly results in extrapulmonary metastasis, including bone, soft tissue of the extremities and retroperitoneum.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> Patients can commonly present with multifocal disease, with the presence of tumour in two or more anatomically distinct sites.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref></p><p>Despite the robust evidence of a high proportion of extrapulmonary metastasis of MLPS, cardiac metastasis is exceedingly rare, with only 48 cases reported worldwide including this publication.<xref rid="R5" ref-type="bibr"><sup>5 6</sup></xref> Cardiac metastases warrant resection if feasible given their high mortality rate; however, factors such as grade of tumour, location of metastasis, risk of perioperative complications such as iatrogenic ventricular septal defect, valvular damage and coronary vasculature damage must be considered.<xref rid="R5" ref-type="bibr"><sup>5 7</sup></xref></p><p>While surgery remains the cornerstone of therapy for extremity MLPS, adjuvant therapy has its role. It has been proposed that among all liposarcomas, MLPS is particularly radiosensitive.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> For extremity MLPS, a general guide to treatment to patients with a resectable tumour is combined surgery with a total en block resection and radiotherapy.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> Similarly, gold standard of treatment for retroperitoneal MLPS metastasis in a sound operative candidate with a resectable lesion is en bloc resection with combined radiotherapy.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref> Despite its known metastatic potential, there is limited research surrounding the use of chemotherapy; however, systemic therapy has shown to have activity in patients with metastatic disease and large, bulky tumours in a neoadjuvant setting.<xref rid="R10" ref-type="bibr"><sup>10</sup></xref></p></sec><sec id="s2"><title>Case presentation</title><p>A man in his mid-50s with a background history of epilepsy initially presented to the hospital with complaints of an anterior thigh mass. He was investigated with an MRI, showing a 22&#215;12.7&#215;9 cm enhancing relatively well-circumscribed mass within the anterior compartment of the right thigh (<xref rid="F1" ref-type="fig">figure 1</xref>).</p><fig position="float" id="F1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><title>MRI MSK gadolinium: heterogeneous 2.2&#215;12.7&#215;9 cm enhancing relatively well-circumscribed mass within the anterior compartment of the right thigh without femoral cortical, marrow involvement or bony destruction.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g001.jpg"/></fig></sec><sec id="s3"><title>Investigations</title><p>This lesion was subsequently biopsied, showing a myxoid liposarcoma. He completed preoperative radiotherapy (50&#8201;Gy/25 fractions) prior to undergoing a wide local excision of right anterior thigh sarcoma under an orthopaedic surgeon.</p><p>The patient participated in yearly surveillance postoperatively. Secondary to severe claustrophobia and anxiety, he was unable to tolerate MRI, and his surveillance was performed with CT. Unfortunately, a surveillance CT/positron emission tomography (PET) suggested bilateral supraclavicular fossa recurrence (<xref rid="F2" ref-type="fig">figure 2</xref>). He completed preoperative/definitive radiotherapy with a total dose of 50&#8201;Gy in 25 fractions.</p><fig position="float" id="F2" fig-type="figure" orientation="portrait"><label>Figure 2</label><caption><title>Positron emission tomography/CT: bilateral supraclavicular fossa masses, the right approximately 50 mm and the leftapproximately 34 mm.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g002.jpg"/></fig><p>After completion of his radiotherapy, he proceeded to a resection of the supraclavicular recurrence under an ear, nose and throat surgeon. He again recovered well, until a surveillance CT showed a 45&#8201;mm soft tissue mass adjacent to the right adrenal gland and a 41&#8201;mm metastasis abutting the right psoas muscle (<xref rid="F3" ref-type="fig">figure 3</xref>).</p><fig position="float" id="F3" fig-type="figure" orientation="portrait"><label>Figure 3</label><caption><title>Coronal CT of the abdomen: 45 mm soft tissue mass adjacent to the right adrenal gland, 41 mm metastasis abutting the right psoas muscle.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g003.jpg"/></fig><p>He underwent radiotherapy to the right adrenal and right psoas muscle metastases, a total of 35&#8201;Gy in five fractions. His surveillance scans were clear for metastasis showing a good tumour response in the treated area, a reduction in size and no new disease.</p><p>A year later, he was again admitted to the hospital with abdominal pain and underwent imaging. A repeat PET scan showed a right iliac fossa soft tissue lesion anterior to the psoas significantly enlarged, raising suspicion for disease recurrence (<xref rid="F4" ref-type="fig">figure 4</xref>). There were stable appearances of the photopenic right adrenal lesion consistent with the treated disease.</p><fig position="float" id="F4" fig-type="figure" orientation="portrait"><label>Figure 4</label><caption><title>Positron emission tomography: 55 mm right iliac fossa soft tissue lesion anterior to the psoas has significantly enlarged and is associated with heterogenous low-grade activity (SUVmax 4.2) having previously been photopenic.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g004.jpg"/></fig><p>His case was referred to the abdominal sarcoma surgeons, and his surgical work-up began. Given a family history of cardiovascular disease, new mild exertional chest pain and an impending prolonged operation, a CT coronary angiogram was performed. This showed filling defect within the right ventricular outflow tract (<xref rid="F5" ref-type="fig">figure 5</xref>). The impression from radiologists was that the location and morphology were almost certainly that of a tumour rather than a bland thrombus.</p><fig position="float" id="F5" fig-type="figure" orientation="portrait"><label>Figure 5</label><caption><title>CT coronary angiography: lobulated filling defect measuring 27&#215;17 mm within the right ventricular outflow tract, possibly invading the intraventricular septum.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g005.jpg"/></fig><p>The case discussed with a cardiothoracic surgeon and cardiac MRI was performed, showing a lobulated intraventricular mass that was commensurate with an intracardiac metastasis (<xref rid="F6" ref-type="fig">figure 6</xref>).</p><fig position="float" id="F6" fig-type="figure" orientation="portrait"><label>Figure 6</label><caption><title>Cardiac MRI: lobulated 32&#215;19&#215;15 mm lesion demonstrated within the right ventricle, at the basalanterior wall towards the right ventricular outflow tract. This is of iso T1 signal and mildly increased T2 signal relative to the skeletal muscle. This is associated with late gadolinium enhancement.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g006.jpg"/></fig></sec><sec id="s4"><title>Treatment</title><p>After extensive discussion between abdominal sarcoma surgeons, the patient and a cardiothoracic surgeon, the patient proceeded to resection of the metastatic deposit in the interventricular septum. This required a reconstruction of the right ventricular outflow tract as well as intraventricular septum. The histology was confirmed to be metastatic myxoid liposarcoma, 42&#8201;mm in size, marginally excised. Wide excision was not possible due to its location within the septum (<xref rid="F7" ref-type="fig">figure 7</xref>).</p><fig position="float" id="F7" fig-type="figure" orientation="portrait"><label>Figure 7</label><caption><title>Tumour is composed of expansile regions of paucicellular hyalinise and sclerotic stroma in which are scattered moderately cellular nodules of rounded to spindled cells. The cells are haphazardly arranged within a partly myxoid background with finely branching capillary vasculature. The tumour cells demonstrate uniform ovoid nuclei with fine chromatin, in distinct nucleoli and small volumes of eosinophilic cytoplasm. Occasional univacuolated lipoblasts are also present. Mitotic figures are rare, and there is no established necrosis. The tumour focally abuts the cardiac muscle margin and is best regarded as marginally excised.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g007.jpg"/></fig><p>The patient recovered remarkably well and proceeded to resection of his intra-abdominal recurrence. This involved colorectal surgery, urology and vascular surgical input. He underwent a laparotomy, excision of right iliac fossa mass with en bloc ileocolic resection, excision of right adrenal metastasis and insertion of the right JJ stent. Intraoperatively, the right iliac fossa mass was approached first. The terminal ileum was involved and a decision made for en bloc ileocolic resection. The right gonadals were unable to be separated from the mass and were taken. At this point, a vascular surgeon scrubbed to identify any invasion of vascular structures surrounding the right adrenal metastasis. The tumour was found to be behind supra-renal inferior vena cava and right kidney. The right adrenal tumour was dissected from peri-nephric fat. A side-to-side ileocolic anastomosis was performed.</p><p>The right-sided adrenal tumour (<xref rid="F8" ref-type="fig">figure 8</xref>) and right iliac fossa mass (<xref rid="F9" ref-type="fig">figure 9</xref>) were sent for histopathology and both returned to metastatic myxoid liposarcoma.</p><fig position="float" id="F8" fig-type="figure" orientation="portrait"><label>Figure 8</label><caption><title>A firm nodular tumour with the adrenal gland and surrounding fat, weighing 263 g in total. The tumour measures 65&#215;55&#215; 35 mm.The tumour focally abuts the circumferential fat margin. The adrenal measures 40 &#215; 30 &#215; 15 mm and is normal, separated from the tumour by 2 mm of the normal fat.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g008.jpg"/></fig><fig position="float" id="F9" fig-type="figure" orientation="portrait"><label>Figure 9</label><caption><title>An ileocolic resection with nodular tumour, overall measuring 190 &#215; 190 &#215; 55 mm. The tumour is situated within the mesenteric fat and is adherent to the external aspect of the mid-point of the ileum, measuring 50 &#215; 45 &#215; 40 mm. It abuts but does not invade the small bowel wall. The tumour appears encapsulated and well circumscribed with the cut surface showing soft semi-solid degenerate contents ranging from pale cream to tan to dark brown. It abuts the circumferential margin.</title></caption><graphic position="float" orientation="portrait" xlink:href="bcr-18-8-g009.jpg"/></fig></sec><sec id="s5"><title>Outcome and follow-up</title><p>The patient spent 9&#8201;days in the hospital and recovered remarkably well. He suffered from a pre-renal acute kidney injury; however, his creatinine returned to normal limits prior to discharge home. At his 6&#8201;week postoperative follow-up, he was tolerating a normal diet and had no complaints of postoperative pain. It has now been 6&#8201;months since his surgery, and he has had no recurrence on his surveillance scans.</p></sec><sec sec-type="discussion" id="s6"><title>Discussion</title><p>Secondary cardiac tumours should be resected in selected patients to prolong life and provide symptom relief.<xref rid="R7" ref-type="bibr">711</xref><xref rid="R14" ref-type="bibr">14</xref> There are factors that would exclude a patient as a candidate for surgical resection, including the size and location of the metastasis, the patient&#8217;s functional baseline and age and their overall prognosis. In a recent review of the literature, surgical resection was attempted in approximately two-thirds of reported cardiac metastasis, which helped to guide the decision to proceed to surgery in this case.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> In patients whom resection is not possible, chemotherapy and radiation can be considered. Two cases have been reported that have been treated with radiotherapy with unclear success rates.<xref rid="R15" ref-type="bibr"><sup>15 16</sup></xref> Two cases have been reported that have been treated primarily with chemotherapy with no response to treatment (although the systemic therapy used was not anthracycline-based).<xref rid="R17" ref-type="bibr"><sup>17 18</sup></xref> In a recent literature review, there have been 41 patients identified myxoid liposarcoma cardiac metastasis, of which 28 were treated with surgical resection<xref rid="R5" ref-type="bibr">57 19</xref><xref rid="R26" ref-type="bibr">26</xref> (<xref rid="T1" ref-type="table">table 1</xref>). The outcomes of surgical resection are variable, and there is limited reported follow-up on patient outcomes postoperatively. However, there is also a paucity of literature with primary treatment with chemoradiation, with only one recent reported case by Stergiopoulos <italic toggle="yes">et al</italic>.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref></p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><title>Peripheral myxoid liposarcoma cardiac metastasis treated with cardiac surgery (since 2010)</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Year published</th><th valign="top" align="left" rowspan="1" colspan="1">Author</th><th valign="top" align="left" rowspan="1" colspan="1">Histology</th><th valign="top" align="left" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">2020</td><td valign="top" align="left" rowspan="1" colspan="1">Ikuta <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myxoid liposarcoma (thigh)</td><td valign="top" align="left" rowspan="1" colspan="1">Confirmed death 2 years later</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2020</td><td valign="top" align="left" rowspan="1" colspan="1">Bezak <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myxoid liposarcoma (gluteal region)</td><td valign="top" align="left" rowspan="1" colspan="1">Alive at the 3&#8201;week follow-up</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2018</td><td valign="top" align="left" rowspan="1" colspan="1">Passhak <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myxoid liposarcoma (ankle)</td><td valign="top" align="left" rowspan="1" colspan="1">Patient alive (on adjuvant chemotherapy) at the 3&#8201;year follow-up</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2014</td><td valign="top" align="left" rowspan="1" colspan="1">Xu <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myxoid liposarcoma (thigh)</td><td valign="top" align="left" rowspan="1" colspan="1">No follow-up reported</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2013</td><td valign="top" align="left" rowspan="1" colspan="1">Pino <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myxoid liposarcoma (shoulder)</td><td valign="top" align="left" rowspan="1" colspan="1">Confirmed death 2&#8201;months later</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2013</td><td valign="top" align="left" rowspan="1" colspan="1">Pino <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Round cell liposarcoma (popliteal fossa)</td><td valign="top" align="left" rowspan="1" colspan="1">Confirmed death 1.5&#8201;months later</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2013</td><td valign="top" align="left" rowspan="1" colspan="1">Mottahedi <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Round cell liposarcoma (knee)</td><td valign="top" align="left" rowspan="1" colspan="1">Patient still alive at 1 year follow-up</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2012</td><td valign="top" align="left" rowspan="1" colspan="1">Agaimy <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myxoid liposarcoma (thigh)</td><td valign="top" align="left" rowspan="1" colspan="1">Confirmed death 2&#8201;months later</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2011</td><td valign="top" align="left" rowspan="1" colspan="1">Dogan <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myxoid liposarcoma (thigh)</td><td valign="top" align="left" rowspan="1" colspan="1">Confirmed death 10&#8201;months later</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2011</td><td valign="top" align="left" rowspan="1" colspan="1">Lazopoulos <italic toggle="yes">et al</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myxoid liposarcoma (thigh)</td><td valign="top" align="left" rowspan="1" colspan="1">No recurrence at 6&#8201;month follow-up</td></tr></tbody></table></table-wrap><p>Given the lack of robust evidence supporting either chemotherapy or radiotherapy for the primary treatment of metastasis MLPS and the fact that the patient&#8217;s lesion was deemed resectable by an experienced cardiothoracic surgeon, the decision was made in a multidisciplinary environment to proceed with resection. Without proceeding promptly to surgery, the patient would have had to undergo months of neoadjuvant therapy prior to his abdominal resection with known rapidly progressive disease. The patient&#8217;s postoperative surveillance will be robust, and systematic therapy with standard care of anthracycline-based therapy or radiotherapy has been reserved as an option for him in the event of local recurrence.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> This plan is based on a case reported by Pino <italic toggle="yes">et al</italic> that demonstrated a complete regression of a right atrial local recurrence following radiotherapy and chemotherapy; however, the dose or regimen was not reported and there is a large gap in the literature that advises treatment.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref></p><p>The Australia and New Zealand Sarcoma Association recommend that patients with suspected sarcoma to be referred to a specialised sarcoma centre for multi-disciplinary management.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> This is based on robust evidence that summarises treatment at high volume centres results in lower rates of local relapse, increased incidence of clear margins on the first surgery and improved local recurrence-free survival.<xref rid="R28" ref-type="bibr"><sup>28 29</sup></xref> Although surgical volume has repeatedly demonstrated correlation with superior outcomes,<xref rid="R28" ref-type="bibr"><sup>28</sup></xref> high case volumes are also likely to be associated with improved oncological outcomes.<xref rid="R30" ref-type="bibr"><sup>30</sup></xref> Because of their rarity and complexity, optimal management of soft tissue sarcomas requires exemplary multi-disciplinary management, often involving surgeons from varying specialties, pathology, radiation oncology, medical oncology and radiology.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref></p><p>Patient outcome is improved on early detection of local recurrence or metastatic disease, which can often be asymptomatic given the indolent nature of some low-grade sarcomas, raising the dilemma of frequency, mode and duration of surveillance.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> Because of the rare nature of sarcomas, there are no standardised guidelines in Australia for recommended surveillance of soft tissue sarcomas. Evidence suggests that the incidence of local recurrence is maximal within the first 5 years of diagnosis and declines with time.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> Other factors such as higher histological grade, penetration of deep fascia and surrounding structures, close or positive margins can all contribute to higher incidence of local recurrence and may warrant more frequent surveillance.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref> High-frequency surveillance programmes with MRI&#177;PET would ensure early detection of local recurrence and distant metastasis; however, it can be a significant burden on healthcare workers and the patient.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> Globally, soft tissue sarcoma surveillance varies among specialist centres, often drawing on anecdotal experience and expertise.<xref rid="R33" ref-type="bibr"><sup>33</sup></xref> Our centre currently performs CT of the chest, abdomen and pelvis on patients highly at risk for sarcoma every 4&#8201;months for the first year, every 6&#8201;months for the second year and then annually up to year 10 postoperatively; however, more research into the area could be conducted to formulate guidelines to avoid overutilisation of radiological services.</p><p>This patient&#8217;s case was diagnosed with a presenting complaint of an anterior thigh lump. He was swiftly referred to the State Sarcoma Service WA. He was in his early 50s at diagnosis, with a tumour size measuring 22 &#215; 12.7 &#215; 9 cm, both conforming to a poor prognosis. Throughout his 5 years of treatment, he has been treated by consultant orthopaedic, ear nose throat, cardiothoracic and colorectal surgeons. He has had specialist input from radiation oncology, pathology, anaesthetic and radiology consultants. He has survived three recurrences, four surgical resections and three cycles of radiotherapy. His case is an example of outstanding interdisciplinary management in the public hospital system in Western Australia. Without succinct communication between consultants and other members throughout multi-disciplinary meetings at a specialised centre, the outcome may not have been quite as remarkable. He will require strict ongoing cardiac and abdominal surveillance, with salvage radiotherapy- and anthracycline-based chemotherapy in the event of recurrence.</p><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Patient&#8217;s perspective</title></caption><sec><title>Words of Advice</title><p>If I were to give advice, it would be this: most importantly, &#8216;get it in your head&#8217; that it is no one&#8217;s fault you have sarcoma. As my life motto goes it simply, &#8216;it is what it is&#8217; and &#8216;you can&#8217;t control the uncontrollable&#8217;. Throughout life, remember &#8216;Life is a gift; live in the present&#8217; and make each day a positive one. I know that&#8217;s easy to say, but it has kept me with this happy demeanour plus never underestimate exercise and eating healthy. You will have good days and bad days&#8212;you&#8217;ve earned that through the process. My multi-disciplinary team are geniuses, and while they may have egos, so do my support network. Between them both, I express my heartfelt thanks from me and my daughters. They are precious and I cherish every moment with them.</p></sec></boxed-text><boxed-text id="BX2" position="float" orientation="portrait"><caption><title>Learning points</title></caption><list list-type="bullet" list-content="ul"><list-item><p>Early referral to a centralised sarcoma unit is paramount to reduce the risk of local recurrence and improve oncological outcomes.</p></list-item><list-item><p>Collaboration and teamwork between surgeons who are experts in their specialty allow the highest standard of care to be delivered to a patient and substantially improve outcomes.</p></list-item><list-item><p>Further research should be conducted to provide guidelines for gold standard treatment of cardiac metastatic myxoid liposarcoma.</p></list-item></list></boxed-text></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p></fn><fn fn-type="other"><p>Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Patient consent for publication:</bold> Consent obtained directly from the patient.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonvalot</surname><given-names>S</given-names></name><name name-style="western"><surname>Gaignard</surname><given-names>E</given-names></name><name name-style="western"><surname>Stoeckle</surname><given-names>E</given-names></name><etal>et al</etal></person-group><article-title>Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database</article-title><source>Ann Surg Oncol</source><year>2019</year><volume>26</volume><fpage>2286</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1245/s10434-019-07421-9</pub-id><pub-id pub-id-type="pmid">31065964</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muratori</surname><given-names>F</given-names></name><name name-style="western"><surname>Bettini</surname><given-names>L</given-names></name><name name-style="western"><surname>Frenos</surname><given-names>F</given-names></name><etal>et al</etal></person-group><article-title>Myxoid Liposarcoma: Prognostic Factors and Metastatic Pattern in a Series of 148 Patients Treated at a Single Institution</article-title><source>Int J Surg Oncol</source><year>2018</year><volume>2018</volume><elocation-id>8928706</elocation-id><pub-id pub-id-type="doi">10.1155/2018/8928706</pub-id><pub-id pub-id-type="pmid">29977616</pub-id><pub-id pub-id-type="pmcid">PMC6011058</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sciot</surname><given-names>R</given-names></name></person-group><article-title>MDM2 Amplified Sarcomas: A Literature Review</article-title><source><italic toggle="yes">Diagnostics (Basel</italic>)</source><year>2021</year><volume>11</volume><elocation-id>496</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics11030496</pub-id><pub-id pub-id-type="pmid">33799733</pub-id><pub-id pub-id-type="pmcid">PMC8001728</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#252;rr</surname><given-names>HR</given-names></name><name name-style="western"><surname>Rauh</surname><given-names>J</given-names></name><name name-style="western"><surname>Baur-Melnyk</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients</article-title><source>BMC Cancer</source><year>2018</year><volume>18</volume><elocation-id>304</elocation-id><pub-id pub-id-type="doi">10.1186/s12885-018-4226-8</pub-id><pub-id pub-id-type="pmid">29558901</pub-id><pub-id pub-id-type="pmcid">PMC5859402</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stergiopoulos</surname><given-names>GM</given-names></name><name name-style="western"><surname>Siontis</surname><given-names>BL</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>IA</given-names></name><etal>et al</etal></person-group><article-title>Cardiac Metastasis from Myxoid Liposarcoma Managed Successfully with Chemotherapy and Radiotherapy: Case Report and Review of the Literature</article-title><source><italic toggle="yes">Curr Oncol</italic></source><year>2024</year><volume>31</volume><fpage>5384</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.3390/curroncol31090398</pub-id><pub-id pub-id-type="pmid">39330026</pub-id><pub-id pub-id-type="pmcid">PMC11431419</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamazaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Kosugi</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>Complete Resection of Cardiac Metastasis Myxoid Liposarcoma</article-title><source>Surg Case Rep</source><year>2025</year><volume>11</volume><elocation-id>25-0138</elocation-id><pub-id pub-id-type="doi">10.70352/scrj.cr.25-0138</pub-id><pub-id pub-id-type="pmcid">PMC12068895</pub-id><pub-id pub-id-type="pmid">40356803</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agaimy</surname><given-names>A</given-names></name><name name-style="western"><surname>R&#246;sch</surname><given-names>J</given-names></name><name name-style="western"><surname>Weyand</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Primary and metastatic cardiac sarcomas: a 12-year experience at a German heart center</article-title><source>Int J Clin Exp Pathol</source><year>2012</year><volume>5</volume><fpage>928</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">23119110</pub-id><pub-id pub-id-type="pmcid">PMC3484490</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guadagnolo</surname><given-names>BA</given-names></name><name name-style="western"><surname>Zagars</surname><given-names>GK</given-names></name><name name-style="western"><surname>Ballo</surname><given-names>MT</given-names></name><etal>et al</etal></person-group><article-title>Excellent Local Control Rates and Distinctive Patterns of Failure in Myxoid Liposarcoma Treated With Conservation Surgery and Radiotherapy</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2008</year><volume>70</volume><fpage>760</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2007.07.2337</pub-id><pub-id pub-id-type="pmid">17892916</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zagars</surname><given-names>GK</given-names></name><name name-style="western"><surname>Goswitz</surname><given-names>MS</given-names></name><name name-style="western"><surname>Pollack</surname><given-names>A</given-names></name></person-group><article-title>Liposarcoma: Outcome and prognostic factors following conservation surgery and radiation therapy</article-title><source>Int J Radiat Oncol Biol Phys</source><year>1996</year><volume>36</volume><fpage>311</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S0360-3016(96)00265-9</pub-id><pub-id pub-id-type="pmid">8892453</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>SR</given-names></name><name name-style="western"><surname>Andrew Burgess</surname><given-names>M</given-names></name><name name-style="western"><surname>Plager</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Myxoid liposarcoma</article-title><source>Experience with Chemotherapy Cancer</source><year>1994</year><volume>74</volume><fpage>1265</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8055448</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0142(19940815)74:4&lt;1265::aid-cncr2820740414&gt;3.0.co;2-x</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>THURBER</surname><given-names>DL</given-names></name><name name-style="western"><surname>EDWARDS</surname><given-names>JE</given-names></name><name name-style="western"><surname>ACHOR</surname><given-names>RW</given-names></name></person-group><article-title>Secondary malignant tumors of the pericardium</article-title><source>Circulation</source><year>1962</year><volume>26</volume><fpage>228</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1161/01.cir.26.2.228</pub-id><pub-id pub-id-type="pmid">14037856</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labib</surname><given-names>SB</given-names></name><name name-style="western"><surname>Schick</surname><given-names>EC</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Isner</surname><given-names>JM</given-names></name></person-group><article-title>Obstruction of right ventricular outflow tract caused by intracavitary metastatic disease: Analysis of 14 cases</article-title><source>J Am Coll Cardiol</source><year>1992</year><volume>19</volume><fpage>1664</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(92)90634-Y</pub-id><pub-id pub-id-type="pmid">1593064</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janigan</surname><given-names>DT</given-names></name><name name-style="western"><surname>Husain</surname><given-names>A</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>NA</given-names></name></person-group><article-title>Cardiac angiosarcomas. A review and a case report</article-title><source>Cancer</source><year>1986</year><volume>57</volume><fpage>852</fpage><lpage>9</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0142(19860215)57:4&amp;#x0003c;852::aid-cncr2820570428&amp;#x0003e;3.0.co;2-s</pub-id><pub-id pub-id-type="pmid">3510706</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Messner</surname><given-names>G</given-names></name><name name-style="western"><surname>Harting</surname><given-names>MT</given-names></name><name name-style="western"><surname>Russo</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Surgical management of metastatic melanoma to the ventricle</article-title><source>Tex Heart Inst J</source><year>2003</year><volume>30</volume><fpage>218</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12959206</pub-id><pub-id pub-id-type="pmcid">PMC197321</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>C</given-names></name><name name-style="western"><surname>Stebbing</surname><given-names>J</given-names></name><name name-style="western"><surname>Judson</surname><given-names>I</given-names></name></person-group><article-title>Cardiac Metastasis from a Myxoid Liposarcoma</article-title><source>Clin Oncol</source><year>2001</year><volume>13</volume><fpage>384</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1007/s001740170041</pub-id><pub-id pub-id-type="pmid">11716235</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>ECK</given-names></name><name name-style="western"><surname>Rubenfeld</surname><given-names>S</given-names></name></person-group><article-title>CARDIAC METASTASIS FROM MYXOID LIPOSARCOMA EMPHASIZING ITS RADIOSENSITIVITY</article-title><source>American Journal of Roentgenology</source><year>1968</year><volume>103</volume><fpage>792</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.2214/ajr.103.4.792</pub-id><pub-id pub-id-type="pmid">5692417</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maloisel</surname><given-names>F</given-names></name><name name-style="western"><surname>Dufour</surname><given-names>P</given-names></name><name name-style="western"><surname>Drawin</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>Embolization of the foramen ovale in metastatic course of abdominal liposarcoma</article-title><source><italic toggle="yes">Ann Cardiol Angeiol (Paris</italic>)</source><year>1991</year><volume>40</volume><fpage>81</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">2024917</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nassif</surname><given-names>EF</given-names></name><name name-style="western"><surname>Keung</surname><given-names>EZ</given-names></name><name name-style="western"><surname>Thirasastr</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Myxoid Liposarcomas: Systemic Treatment Options</article-title><source>Curr Treat Options Oncol</source><year>2023</year><volume>24</volume><fpage>274</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1007/s11864-023-01057-4</pub-id><pub-id pub-id-type="pmid">36853469</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikuta</surname><given-names>K</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>T</given-names></name><name name-style="western"><surname>Koike</surname><given-names>H</given-names></name><etal>et al</etal></person-group><article-title>Cardiac metastases from primary myxoid liposarcoma of the thigh: a case report</article-title><source>World J Surg Oncol</source><year>2020</year><volume>18</volume><elocation-id>227</elocation-id><pub-id pub-id-type="doi">10.1186/s12957-020-02009-0</pub-id><pub-id pub-id-type="pmid">32854723</pub-id><pub-id pub-id-type="pmcid">PMC7457307</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mottahedi</surname><given-names>B</given-names></name><name name-style="western"><surname>Asadi</surname><given-names>M</given-names></name><name name-style="western"><surname>Amini</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Round Cell Liposarcoma Metastatic to the Heart</article-title><source><italic toggle="yes">J Card Surg</italic></source><year>2013</year><volume>28</volume><fpage>672</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/jocs.12148</pub-id><pub-id pub-id-type="pmid">23808478</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pino</surname><given-names>PG</given-names></name><name name-style="western"><surname>Zampi</surname><given-names>G</given-names></name><name name-style="western"><surname>Pergolini</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Metastatic liposarcoma of the heart. Case series and brief literature review</article-title><source>Herz</source><year>2013</year><volume>38</volume><fpage>938</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s00059-013-3768-4</pub-id><pub-id pub-id-type="pmid">23436031</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Anesthetic management of the removal of a giant metastatic cardiac liposarcoma occupying right ventricle and pulmonary artery</article-title><source>J Cardiothorac Surg</source><year>2014</year><volume>9</volume><elocation-id>56</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8090-9-56</pub-id><pub-id pub-id-type="pmid">24655329</pub-id><pub-id pub-id-type="pmcid">PMC3974594</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Passhak</surname><given-names>M</given-names></name><name name-style="western"><surname>Amsalem</surname><given-names>Y</given-names></name><name name-style="western"><surname>Vlodavsky</surname><given-names>E</given-names></name><etal>et al</etal></person-group><article-title>Cerebral Liposarcoma Embolus From Heart Metastasis Successfully Treated by Endovascular Extraction Followed by Cardiac Surgery</article-title><source>Vasc Endovascular Surg</source><year>2018</year><volume>52</volume><fpage>653</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1177/1538574418783527</pub-id><pub-id pub-id-type="pmid">29940813</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bezak</surname><given-names>B</given-names></name><name name-style="western"><surname>Artemiou</surname><given-names>P</given-names></name><name name-style="western"><surname>Hulman</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Metastatic myxoid liposarcoma of the interventricular septum</article-title><source>J Card Surg</source><year>2020</year><volume>35</volume><fpage>662</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1111/jocs.14422</pub-id><pub-id pub-id-type="pmid">31945222</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazopoulos</surname><given-names>G</given-names></name><name name-style="western"><surname>Papastavrou</surname><given-names>L</given-names></name><name name-style="western"><surname>Kantartzis</surname><given-names>M</given-names></name></person-group><article-title>Giant metastatic cardiac and abdominal liposarcomas causing hemodynamic deterioration</article-title><source>Thorac Cardiovasc Surg</source><year>2011</year><volume>59</volume><fpage>121</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1250099</pub-id><pub-id pub-id-type="pmid">21384310</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dogan</surname><given-names>U</given-names></name><name name-style="western"><surname>Zamani</surname><given-names>A</given-names></name><name name-style="western"><surname>Gormus</surname><given-names>N</given-names></name><etal>et al</etal></person-group><article-title>The first case report of a metastatic myxoid liposarcoma invading the left atrial cavity and pulmonary vein</article-title><source><italic toggle="yes">Heart Surg Forum</italic></source><year>2011</year><volume>14</volume><fpage>E261</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1532/HSF98.20111021</pub-id><pub-id pub-id-type="pmid">21859649</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>AM</given-names></name><name name-style="western"><surname>Lo</surname><given-names>H</given-names></name><name name-style="western"><surname>Lawless</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>The benefit for radiotherapy at specialised sarcoma centres: A systematic review and clinical practice guidelines from the Australia and New Zealand Sarcoma Association</article-title><source>Radiother Oncol</source><year>2022</year><volume>177</volume><fpage>158</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.radonc.2022.10.037</pub-id><pub-id pub-id-type="pmid">36336110</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagaria</surname><given-names>SP</given-names></name><name name-style="western"><surname>Neville</surname><given-names>M</given-names></name><name name-style="western"><surname>Gray</surname><given-names>RJ</given-names></name><etal>et al</etal></person-group><article-title>The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume Institutions</article-title><source>Sarcoma</source><year>2018</year><volume>2018</volume><elocation-id>3056562</elocation-id><pub-id pub-id-type="doi">10.1155/2018/3056562</pub-id><pub-id pub-id-type="pmid">30140165</pub-id><pub-id pub-id-type="pmcid">PMC6081523</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawai</surname><given-names>K</given-names></name><name name-style="western"><surname>Kandori</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Impact of centralization in primary retroperitoneal sarcoma treatment: analysis using hospital-based cancer registry data in Japan</article-title><source>Int J Clin Oncol</source><year>2020</year><volume>25</volume><fpage>1687</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1007/s10147-020-01709-7</pub-id><pub-id pub-id-type="pmid">32451766</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blay</surname><given-names>J-Y</given-names></name><name name-style="western"><surname>Honor&#233;</surname><given-names>C</given-names></name><name name-style="western"><surname>Stoeckle</surname><given-names>E</given-names></name><etal>et al</etal></person-group><article-title>Surgery in reference centers improves survival of sarcoma patients: a nationwide study</article-title><source>Ann Oncol</source><year>2019</year><volume>30</volume><fpage>1143</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdz124</pub-id><pub-id pub-id-type="pmid">31081028</pub-id><pub-id pub-id-type="pmcid">PMC6637376</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ray-Coquard</surname><given-names>I</given-names></name><name name-style="western"><surname>Thiesse</surname><given-names>P</given-names></name><name name-style="western"><surname>Ranch&#232;re-Vince</surname><given-names>D</given-names></name><etal>et al</etal></person-group><article-title>Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas</article-title><source>Ann Oncol</source><year>2004</year><volume>15</volume><fpage>307</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdh058</pub-id><pub-id pub-id-type="pmid">14760127</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cipriano</surname><given-names>CA</given-names></name><name name-style="western"><surname>Jang</surname><given-names>E</given-names></name><name name-style="western"><surname>Tyler</surname><given-names>W</given-names></name></person-group><article-title>Sarcoma Surveillance: A Review of Current Evidence and Guidelines</article-title><source><italic toggle="yes">J Am Acad Orthop Surg</italic></source><year>2020</year><volume>28</volume><fpage>145</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.5435/JAAOS-D-19-00002</pub-id><pub-id pub-id-type="pmid">31651565</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitaker</surname><given-names>J</given-names></name><name name-style="western"><surname>Nessim</surname><given-names>C</given-names></name><name name-style="western"><surname>Almond</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma</article-title><source><italic toggle="yes">Curr Oncol</italic></source><year>2023</year><volume>30</volume><fpage>2781</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.3390/curroncol30030211</pub-id><pub-id pub-id-type="pmid">36975424</pub-id><pub-id pub-id-type="pmcid">PMC10047263</pub-id></element-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>